rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2001-10-5
|
pubmed:abstractText |
To utilize power spectral analysis (PSA) of heart rate variability (HRV) as a pharmacodynamic (PD) measure of atropine parasympathetic effect, and to model the kinetics of action.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0724-8741
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1220-5
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11587495-Animals,
pubmed-meshheading:11587495-Atropine,
pubmed-meshheading:11587495-Catheterization, Peripheral,
pubmed-meshheading:11587495-Heart Rate,
pubmed-meshheading:11587495-Male,
pubmed-meshheading:11587495-Models, Biological,
pubmed-meshheading:11587495-Parasympatholytics,
pubmed-meshheading:11587495-Rats,
pubmed-meshheading:11587495-Signal Processing, Computer-Assisted,
pubmed-meshheading:11587495-Telemetry
|
pubmed:year |
2001
|
pubmed:articleTitle |
Power spectral analysis of heart rate variability in rats as a quantitative tool in the PK-PD analysis of the parasympatholytic activity of atropine.
|
pubmed:affiliation |
Department of Pharmaceutics, School of Pharmacy, The Hebrew University of Jerusalem, Israel.
|
pubmed:publicationType |
Journal Article
|